Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
Asahi Kasei consolidates years of global dealmaking into a single brand
Asahi Kasei has wrapped its years of global dealmaking into a single brand, according to a Fierce Pharma report.
2022
Asahi Kasei and Genomatica partner to develop bio-based HMD
Asahi Kasei formed a strategic partnership with Genomatica to develop biomass-derived hexamethylenediamine (HMD). The alliance gives Asahi Kasei preferential rights to access early volumes of bio-HMD for evaluation and trials.
2021
Everactive closes $35 million funding round
Everactive closed a $35 million funding round led by Fluke Corp. The new funding will be used to accelerate sales, marketing, and product development in the industrial sector.
2020
Hongda Xingye and Asahi Kasei sign hydrogen cooperation framework agreement
Hongda Xingye and Asahi Kasei signed a framework agreement to cooperate in chlor-alkali hydrogen production and related hydrogen technologies. The article says specific cooperation matters would be set out in later legal documents.